What it takes to bring an AI research assistant to thousands of medical experts
AI-summarised brief · reviewed before publication
Microsoft and Novo Nordisk’s joint team rebuilt a clinical‑trial data analysis agent, moving it from Azure Container Apps to a hosted agent model in Microsoft Foundry. The new architecture isolates each user session in a VM‑sandbox, provides on‑demand compute, and leverages Foundry’s built‑in scaling, tracing, evaluation and governance tools. By offloading container scaling, session lifecycle and networking to the platform, the team reduced operational overhead while preserving security controls such as access policies and private telemetry. The agent interprets researchers’ ad‑hoc queries, generates and runs analysis code, iterates on results, and returns visual summaries, enabling thousands of medical experts to conduct secondary analyses without custom infrastructure. The migration also introduced systematic quality measurement and continuous improvement loops tied to expert‑validated answers.
💡 Why It Matters
- · The shift gives pharmaceutical researchers instant, secure access to AI‑driven analytics at scale, turning exploratory queries into actionable insights without the burden of managing complex cloud infrastructure.
